AZD2014 and Weekly Paclitaxel in Squamous NSCLC

Trial Identifier: D2274C00001
Sponsor: AstraZeneca
NCTID:: NCT02403895
Start Date: April 2015
Primary Completion Date: December 2016
Study Completion Date: December 2016
Condition: Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Germany Gauting, Germany, 82131
Spain Barcelona, Spain, 08035
Spain Barcelona, Spain, 08028
Spain Girona, Spain, 17007
Spain Majadahonda, Spain, 28222
United States of America, MA Boston, MA, United States of America, 02215
United States of America, MI Detroit, MI, United States of America, 48201
United States of America, PA Hershey, PA, United States of America, 17022
United States of America, TX Dallas, TX, United States of America, 75251